The Latest Breaking News from Multiple Sclerosis

The 400m hurdler took to the start line at the Commonwealth Games for the first time since revealing she had been diagnosed with relapsing remitting MS aged 17

Debbie Edwards won't let anything stop her achieving her goals - this year she's joining the Great North Run

Lina Nielsen makes her debut at the Comonwealth Games this week, and ahead of it the British athlete has bravely revealed her multiple sclerosis diagnosis

Weeks after returning to Scotland from Morocco, Linda Hoskins was diagnosed with Multiple Sclerosis (MS).

ALMOST 600 patients were diagnosed with multiple sclerosis (MS) in Scotland in 2021.

Antony Butcher reaches San Francisco after pedalling 4,000 miles from New York and raising £25,000

The FDA has placed Sanofi SA's (NASDAQ:SNY) Phase 3 studies of tolebrutinib in multiple sclerosis and myasthenia gravis on partial clinical hold.  New enrollment in the U.S. is paused, and participants in the U.S. who have been in the trial for fewer than 60 days shall suspend the study drug.  The participants who…

Jazz Pharmaceuticals (NASDAQ: JAZZ) announced top-line results from the Phase 3 clinical trial investigating nabiximols oromucosal spray (JZP378) on clinical measures of spasticity in individuals with multiple sclerosis (MS).

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) announced topline results from the Phase 3 RELEASE MSS1 trial of nabiximols oromucosal spray on clinical measures of spasticity in multiple sclerosis.  The trial did not meet the primary endpoint of change in Lower Limb Muscle Tone-6 (LLMT-6) between baseline and Day 21. Nabiximols oromucosal spray is a complex…

"Our results are a window of opportunity for new research strategies of demyelinating diseases such as MS."

MMJ companies are building a center of marijuana excellence in Rhode Island and has filed for FDA sanctioned clinical trials in multiple sclerosis and Huntington's disease. MMJ was awarded the much coveted orphan drug designation from the FDA for its planned Huntington's disease trials, and has also received a D